Triple-negative Breast Cancer: Clinical Trials

2 trials for Triple-negative Breast Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Not yet recruiting 1, Recruiting 1

Follow Triple-negative Breast Cancer: new trials by email Literature Review of Triple-negative Breast Cancer trials Research Report on Triple-negative Breast Cancer

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer
Taxane and Carboplatin, Short-term Sintilimab, Surgery - Triple-negative Breast Cancer
Phase 4Not yet recruitingShanghai Jiao Tong University School of Medicine482023-07-012023-06-06
Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Huaier Granule - Carcinoma Breast, Triple-negative Breast Cancer
Phase 4RecruitingFudan University10722021-06-182024-06-27

Narrower conditions

Triple Negative Breast Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Ductal, Breast (1)

Broader conditions

Breast Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Adenocarcinoma (1)  ·  Breast Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Ductal (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Ductal, Lobular, and Medullary (1)  ·  Neoplasms, Glandular and Epithelial (1)

Interventions

Carboplatin (1)  ·  Surgical Procedures, Operative (1)  ·  taxane (1)

Sponsors

Fudan University (1)  ·  Shanghai Jiao Tong University School of Medicine (1)

Countries

China (1)

Top investigators

Zhimin Shao, PhD (1)